Letter from Dr Joanne Kennedy (Business Manager, Biotechnology Unit) to Dr C R M Hay (Manchester Royal Infirmary), re Meeting with Charles Lister concerning inhibitor treatment. States that their objective was to get the current Ministerial Guidance on recombinant products extended to people with haemophilia and inhibitors